Dmitri Lissin, MD

Chief Medical Officer
Scilex Holding Company
Palo Alto, California

Disclosure information not submitted.

Presentation(s):

• Pain freedom with celecoxib oral solution, ubrogepant, and rimegepant through 4 hours postdose: post hoc analysis in the acute treatment of migraine

  POSTER ABSTRACT